Compare $CLDI vs $ORGS | Chartloom

Compare

$CLDI vs $ORGS

Calidi Biotherapeutics Inc · Orgenesis Inc

CLDI

Calidi Biotherapeutics Inc

ORGS

Orgenesis Inc

Compare $CLDI vs $ORGS

Comparing Calidi Biotherapeutics Inc and Orgenesis Inc

CLDICalidi Biotherapeutics Inc

ORGSOrgenesis Inc

CLDICalidi Biotherapeutics Inc

Market cap

$20M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-94.5%

52W performance

-96.0%

FCF yield

-89.7%

ORGSOrgenesis Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.8%

YTD performance

133.3%

52W performance

-56.3%

FCF yield

-505.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CLDI

ORGS

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

ORGS

Orgenesis Inc

Market Cap

CLDI$20M

ORGS$3M

Enterprise Value

CLDI$17M

ORGS$20M

Price

CLDI$1.03

ORGS$0.35

P/E Ratio

CLDIN/A

ORGSN/A

P/S Ratio

CLDI0.00x

ORGS3.31x

EV/Sales

CLDI0.00x

ORGS19.39x

EV/EBITDA

CLDI0.00x

ORGS0.00x

P/B Ratio

CLDI1.27x

ORGS0.28x

P/FCF Ratio

CLDIN/A

ORGSN/A

EV/FCF

CLDI-0.94x

ORGS-1.16x

PEG Ratio

CLDIN/A

ORGSN/A

Forward P/E (NTM)

CLDIN/A

ORGSN/A

Forward P/S (NTM)

CLDIN/A

ORGSN/A

Revenue (TTM)

CLDI$0

ORGS$1M

Revenue Growth (YoY)

CLDIN/A

ORGS-92.8%

Forward Rev Growth

CLDI0.0%

ORGS0.0%

Gross Margin (TTM)

CLDI0.0%

ORGS-86.3%

Operating Margin (TTM)

CLDI0.0%

ORGS0.0%

EBITDA Margin (TTM)

CLDI0.0%

ORGS-1868.2%

Net Margin (TTM)

CLDI0.0%

ORGS-4653.6%

FCF Margin (TTM)

CLDIN/A

ORGS-1675.3%

Net Income (TTM)

CLDI$-23M

ORGS$-48M

FCF (TTM)

CLDI$-18M

ORGS$-17M

EPS (TTM)

CLDI-$265.03

ORGS-$9.58

ROE (TTM)

CLDI-37285.0%

ORGS-10936.0%

ROA (TTM)

CLDI-17613.0%

ORGS-20820.0%

ROIC (TTM)

CLDI-30694.0%

ORGS-5864.0%

Cash

CLDI$4M

ORGS$78K

Debt

CLDI$928K

ORGS$17M

Net Cash/Debt

CLDI$3M

ORGS$-17M

Current Ratio (TTM)

CLDI1.68x

ORGS0.03x

Quick Ratio (TTM)

CLDI1.55x

ORGS0.03x

Debt/Equity (TTM)

CLDI0.30x

ORGS1.73x

Debt/Assets (TTM)

CLDI0.0%

ORGS0.0%

Interest Coverage (TTM)

CLDIN/A

ORGSN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

ORGS0.00x

Beta

CLDI1.37

ORGS3.73

52W Performance

CLDI-96.0%

ORGS-56.3%

YTD Performance

CLDI-94.5%

ORGS133.3%

% from 52W High

CLDI-96.3%

ORGS-65.0%

% from 52W Low

CLDI4.5%

ORGS34900.0%

Asset Turnover (TTM)

CLDI0.00x

ORGS0.04x

FCF Yield (TTM)

CLDI-89.7%

ORGS-505.5%

Earnings Yield (TTM)

CLDI-117.9%

ORGS-1404.2%

Dividend Yield (TTM)

CLDIN/A

ORGSN/A

Rule of 40

CLDI0.0

ORGS-1,768.0

EV/GP/RG

CLDIN/A

ORGSN/A

Ticker research

View CLDI research View ORGS research

Metric	CLDI Calidi Biotherapeutics Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$20M	$3M
Enterprise Value	$17M	$20M
Price	$1.03	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.31x
EV/Sales	0.00x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1868.2%
Net Margin (TTM)	0.0%	-4653.6%
FCF Margin (TTM)	N/A	-1675.3%
Net Income (TTM)	$-23M	$-48M
FCF (TTM)	$-18M	$-17M
EPS (TTM)	-$265.03	-$9.58
ROE (TTM)	-37285.0%	-10936.0%
ROA (TTM)	-17613.0%	-20820.0%
ROIC (TTM)	-30694.0%	-5864.0%
Financial Health
Cash	$4M	$78K
Debt	$928K	$17M
Net Cash/Debt	$3M	$-17M
Current Ratio (TTM)	1.68x	0.03x
Quick Ratio (TTM)	1.55x	0.03x
Debt/Equity (TTM)	0.30x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	3.73
52W Performance	-96.0%	-56.3%
YTD Performance	-94.5%	133.3%
% from 52W High	-96.3%	-65.0%
% from 52W Low	4.5%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-89.7%	-505.5%
Earnings Yield (TTM)	-117.9%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View ORGS research

Valuation

P/S Ratio

CLDI

0.00x

ORGS

3.31x

EV/FCF

ORGS

-1.16x

CLDI

-0.94x

Growth & revenue

Revenue Growth TTM

ORGS

-92.8%

Forward Revenue Growth

CLDI

0.0%

ORGS

0.0%

Profitability & performance

Gross Margin

CLDI

0.0%

ORGS

-86.3%

ROE

ORGS

-10936.0%

CLDI

-37285.0%

FCF Yield %

CLDI

-89.7%

ORGS

-505.5%

52-Week Performance

ORGS

-56.3%

CLDI

-96.0%

Detailed metrics comparison

CLDI

Calidi Biotherapeutics Inc

ORGS

Orgenesis Inc

Market Cap

CLDI$20M

ORGS$3M

Enterprise Value

CLDI$17M

ORGS$20M

Price

CLDI$1.03

ORGS$0.35

P/E Ratio

CLDIN/A

ORGSN/A

P/S Ratio

CLDI0.00x

ORGS3.31x

EV/Sales

CLDI0.00x

ORGS19.39x

EV/EBITDA

CLDI0.00x

ORGS0.00x

P/B Ratio

CLDI1.27x

ORGS0.28x

P/FCF Ratio

CLDIN/A

ORGSN/A

EV/FCF

CLDI-0.94x

ORGS-1.16x

PEG Ratio

CLDIN/A

ORGSN/A

Forward P/E (NTM)

CLDIN/A

ORGSN/A

Forward P/S (NTM)

CLDIN/A

ORGSN/A

Revenue (TTM)

CLDI$0

ORGS$1M

Revenue Growth (YoY)

CLDIN/A

ORGS-92.8%

Forward Rev Growth

CLDI0.0%

ORGS0.0%

Gross Margin (TTM)

CLDI0.0%

ORGS-86.3%

Operating Margin (TTM)

CLDI0.0%

ORGS0.0%

EBITDA Margin (TTM)

CLDI0.0%

ORGS-1868.2%

Net Margin (TTM)

CLDI0.0%

ORGS-4653.6%

FCF Margin (TTM)

CLDIN/A

ORGS-1675.3%

Net Income (TTM)

CLDI$-23M

ORGS$-48M

FCF (TTM)

CLDI$-18M

ORGS$-17M

EPS (TTM)

CLDI-$265.03

ORGS-$9.58

ROE (TTM)

CLDI-37285.0%

ORGS-10936.0%

ROA (TTM)

CLDI-17613.0%

ORGS-20820.0%

ROIC (TTM)

CLDI-30694.0%

ORGS-5864.0%

Cash

CLDI$4M

ORGS$78K

Debt

CLDI$928K

ORGS$17M

Net Cash/Debt

CLDI$3M

ORGS$-17M

Current Ratio (TTM)

CLDI1.68x

ORGS0.03x

Quick Ratio (TTM)

CLDI1.55x

ORGS0.03x

Debt/Equity (TTM)

CLDI0.30x

ORGS1.73x

Debt/Assets (TTM)

CLDI0.0%

ORGS0.0%

Interest Coverage (TTM)

CLDIN/A

ORGSN/A

Net Debt/EBITDA (TTM)

CLDI0.00x

ORGS0.00x

Beta

CLDI1.37

ORGS3.73

52W Performance

CLDI-96.0%

ORGS-56.3%

YTD Performance

CLDI-94.5%

ORGS133.3%

% from 52W High

CLDI-96.3%

ORGS-65.0%

% from 52W Low

CLDI4.5%

ORGS34900.0%

Asset Turnover (TTM)

CLDI0.00x

ORGS0.04x

FCF Yield (TTM)

CLDI-89.7%

ORGS-505.5%

Earnings Yield (TTM)

CLDI-117.9%

ORGS-1404.2%

Dividend Yield (TTM)

CLDIN/A

ORGSN/A

Rule of 40

CLDI0.0

ORGS-1,768.0

EV/GP/RG

CLDIN/A

ORGSN/A

Ticker research

View CLDI research View ORGS research

Metric	CLDI Calidi Biotherapeutics Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$20M	$3M
Enterprise Value	$17M	$20M
Price	$1.03	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	3.31x
EV/Sales	0.00x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.27x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.94x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-1868.2%
Net Margin (TTM)	0.0%	-4653.6%
FCF Margin (TTM)	N/A	-1675.3%
Net Income (TTM)	$-23M	$-48M
FCF (TTM)	$-18M	$-17M
EPS (TTM)	-$265.03	-$9.58
ROE (TTM)	-37285.0%	-10936.0%
ROA (TTM)	-17613.0%	-20820.0%
ROIC (TTM)	-30694.0%	-5864.0%
Financial Health
Cash	$4M	$78K
Debt	$928K	$17M
Net Cash/Debt	$3M	$-17M
Current Ratio (TTM)	1.68x	0.03x
Quick Ratio (TTM)	1.55x	0.03x
Debt/Equity (TTM)	0.30x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.37	3.73
52W Performance	-96.0%	-56.3%
YTD Performance	-94.5%	133.3%
% from 52W High	-96.3%	-65.0%
% from 52W Low	4.5%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-89.7%	-505.5%
Earnings Yield (TTM)	-117.9%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View CLDI research	View ORGS research